ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MO vs LLY // RETURN ON INVESTED CAPITAL (ROIC)

Altria Group Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: MO 7 — LLY 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MO VS. LLY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MO LLY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.50% 83.64% -21.14 LLY /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE 48.40% 32.36% +16.04 MO /roic <GO>
EV/EBITDA & P/E Valuation 14.7x 36.4x -21.72 MO /valuation <GO>
Free Cash Flow Yield 7.08% 2.30% +4.78 MO /fcf-yield <GO>
Operating Margin 42.50% 40.21% +2.29 MO /operating-margins <GO>
Net Profit Margin 29.80% 31.90% -2.10 LLY /net-margins <GO>
Revenue Growth (YoY) -3.10% 45.51% -48.61 LLY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.43% 0.49% +4.94 MO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.90 9.29 -4.39 LLY /balance-sheet <GO>
Piotroski F-Score Quality 6/9 9/9 -3.00 LLY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — 6.77% — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 63.7 66.6 -2.90 LLY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.92 0.51 +0.41 MO /macro-sensitivity <GO>
Forward P/E Multiple 17.1x 26.3x -9.15 MO /forward-pe <GO>
Enterprise Scale & Market Cap $128.15B $1.29T -$1.16T LLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MO REV LLY REV MO GROSS % LLY GROSS % MO FCF LLY FCF
FY 2025 $23.28B $65.18B 62.5% 83.0% $9.07B $16.81B
FY 2024 $24.02B $45.04B 59.8% 81.3% $8.61B $8.82B
FY 2023 $24.48B $34.12B — 79.3% $8.19B $4.24B
FY 2022 — $28.54B — 76.8% — $7.59B
FY 2021 — $28.32B — 74.2% — $7.37B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MO // BETA 0.92
LLY // BETA 0.51